Finance

Lists
300016:SHE
Beijing Beilu Pharmaceutical Co Ltd
CN¥9.16
-0.22%
(-0.020) 1D
Oct 9, 3:04:28 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300016...
Open
CN¥9.13
High
CN¥9.22
Low
CN¥8.77
Mkt. cap
5.34B
Avg. vol.
41.96M
Volume
26.45M
Dividend
0.66%
Quarterly dividend
CN¥0.02
Ex-dividend date
Sep 23, 2026
P/E ratio
35.55
52-wk high
CN¥11.38
52-wk low
CN¥7.08
EPS
CN¥0.26
Shares outstanding
581.69M
No. of employees
1K
Open
CN¥9.13
High
CN¥9.22
Low
CN¥8.77
Mkt. cap
5.34B
Avg. vol.
41.96M
Volume
26.45M
Dividend
0.66%
Quarterly dividend
CN¥0.02
Ex-dividend date
Sep 23, 2026
P/E ratio
35.55
52-wk high
CN¥11.38
52-wk low
CN¥7.08
EPS
CN¥0.26
Shares outstanding
581.69M
No. of employees
1K
News stories
From web sources and news partners
About Beijing Beilu Pharmaceutical Co Ltd
CEO-
Employees1.19K
FoundedSep 5, 1992
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
288.48M
332.59M
320.37M
352.96M
Cost of goods sold
160.62M
189.95M
171.34M
209.05M
Cost of revenue
160.62M
189.95M
171.34M
209.05M
Research and development expenses
24.94M
29.43M
15.45M
14.76M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
84.78M
97.35M
84.08M
78.55M
Operating expense
108.76M
130.35M
98.63M
94.66M
Total operating expenses
269.38M
320.30M
269.97M
303.71M
Operating income
19.10M
12.29M
50.40M
49.25M
Other non operating income
-1.97M
1.55M
-3.19M
3.18M
EBT including unusual items
14.93M
63.53M
54.70M
46.34M
EBT excluding unusual items
14.68M
10.67M
50.52M
48.04M
Income tax expense
2.40M
14.35M
8.54M
7.32M
Effective tax rate
16.10%
22.58%
15.62%
15.80%
Other operating expenses
-820.45K
1.18M
97.64K
1.21M
Net income
14.21M
48.56M
44.98M
34.78M
Net profit margin
4.93%
14.60%
14.04%
9.85%
Earnings per share
-
-
-
-
Interest and investment income
6.81M
2.45M
6.71M
5.28M
Interest expense
-9.66M
-2.58M
-3.39M
-3.40M
Net interest expenses
-2.85M
-136.14K
3.31M
1.88M
Depreciation and amortization charges
-
-
-
-
EBITDA
41.65M
36.01M
74.12M
73.80M
Gain or loss from assets sale
-1.27M
1.23M
-
-
AI content may include mistakes. Learn more
Google apps